BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31696212)

  • 21. Short Communication: Carotid Intima-Media Thickness Is Not Associated with Neurocognitive Impairment Among People Older than 50 Years With and Without HIV Infection from Thailand.
    Hiransuthikul A; Chutinet A; Sakulrak S; Samajarn J; Vongsayan P; Kijpaisalratana N; Akarathanawat W; Apornpong T; Sangarlangkarn A; Gatechompol S; Han WM; Chattranukulchai P; Kerr S; Ruxrungtham K; Avihingsanon A
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1170-1173. PubMed ID: 31588776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-frailty predicts cognitive decline at 2-year follow-up in persons living with HIV.
    Paolillo EW; Sun-Suslow N; Pasipanodya EC; Morgan EE; Ellis RJ; Jeste DV; Moore DJ
    J Neurovirol; 2020 Apr; 26(2):168-180. PubMed ID: 31858484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS.
    Tu W; Chen PA; Koenig N; Gomez D; Fujiwara E; Gill MJ; Kong L; Power C
    J Neurovirol; 2020 Feb; 26(1):41-51. PubMed ID: 31520320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV.
    Watson CW; Paolillo EW; Morgan EE; Umlauf A; Sundermann EE; Ellis RJ; Letendre S; Marcotte TD; Heaton RK; Grant I
    J Acquir Immune Defic Syndr; 2020 Jan; 83(1):56-64. PubMed ID: 31809361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of neurocognitive deficits in people living with HIV in Sub Saharan Africa: A systematic review.
    Nyamayaro P; Chibanda D; Robbins RN; Hakim J; Gouse H
    Clin Neuropsychol; 2019; 33(sup1):1-26. PubMed ID: 31043112
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolic Syndrome and Neurocognitive Deficits in HIV Infection.
    Yu B; Pasipanodya E; Montoya JL; Moore RC; Gianella S; McCutchan A; Ellis R; Heaton RK; Jeste DV; Moore DJ; Marquine MJ
    J Acquir Immune Defic Syndr; 2019 May; 81(1):95-101. PubMed ID: 30664077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-Associated Neurocognitive Disorders: The First Longitudinal Follow-Up of a cART-Treated Cohort of Older People in Sub-Saharan Africa.
    Spooner R; Ranasinghe S; Urasa S; Yoseph M; Koipapi S; Mukaetova-Ladinska EB; Lewis T; Howlett W; Dekker M; Kisoli A; Gray WK; Walker RW; Dotchin CL; Kalaria R; Lwezuala B; Makupa PC; Akinyemi R; Paddick SM
    J Acquir Immune Defic Syndr; 2022 Jun; 90(2):214-222. PubMed ID: 35125473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional deficits and other psychiatric associations with abnormal scores on the Montreal Cognitive Assessment (MoCA) in older HIV-infected patients.
    Bourgeois JA; John M; Zepf R; Greene M; Frankel S; Hessol NA
    Int Psychogeriatr; 2020 Jan; 32(1):105-118. PubMed ID: 31014404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of HIV-Associated Neurocognitive Impairment in Middle-Aged and Older Persons With HIV in Lima, Peru.
    Diaz MM; Zacarías MG; Sotolongo P; Sanes MF; Franklin DJ; Marquine MJ; Cherner M; Cárcamo C; Ellis RJ; Lanata S; García PJ
    Front Neurol; 2021; 12():629257. PubMed ID: 34220665
    [No Abstract]   [Full Text] [Related]  

  • 30. The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland.
    Santos G; Locatelli I; Métral M; Berney A; Nadin I; Calmy A; Tarr P; Gutbrod K; Hauser C; Brugger P; Kovari H; Kunze U; Stoeckle M; Früh S; Schmid P; Rossi S; Di Benedetto C; Du Pasquier R; Darling K; Cavassini M;
    Int J STD AIDS; 2021 Jul; 32(8):729-739. PubMed ID: 33629882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a neurocognitive test battery for HIV-associated neurocognitive disorder (HAND) screening: suggested solutions for resource-limited clinical settings.
    Chan LG; Ho MJ; Lin YC; Ong Y; Wong CS
    AIDS Res Ther; 2019 Apr; 16(1):9. PubMed ID: 30987670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
    Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
    AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations Between Neurocognitive Impairment and Biomarkers of Poor Physiologic Reserve in a Clinic-Based Sample of Older Adults Living with HIV.
    Yu KC; D'Avanzo PA; Nesheiwat L; Greene RE; Urbina A; Halkitis PN; Kapadia F
    J Assoc Nurses AIDS Care; 2017; 28(1):55-66. PubMed ID: 27639980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple screening for neurocognitive impairment in routine HIV outpatient care: is it deliverable?
    Parry S; Zetler S; Kentridge A; Petrak J; Barber T
    AIDS Care; 2017 Oct; 29(10):1275-1279. PubMed ID: 28292203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efavirenz use and neurocognitive performance among older people living with HIV who were on antiretroviral therapy.
    Qin P; He J; Wang Z; Chen X; Li J; Fung AWT; Jiang H; Chen J; Wong A; Lau JTF
    AIDS Care; 2020 Jan; 32(1):12-20. PubMed ID: 31142146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Montreal Cognitive Assessment Performance in HIV/AIDS: Impact of Systemic Factors.
    Koenig N; Fujiwara E; Gill MJ; Power C
    Can J Neurol Sci; 2016 Jan; 43(1):157-62. PubMed ID: 26635008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of cognitive reserve in mediating HIV-associated neurocognitive disorders in older adults living with-treated HIV in Mbeya, Tanzania: A cross-sectional observational study.
    M S; E K; N TR; E C; K S; Kaminyoge MS; B M; R W; G L; W K G; S-M P; B M
    Int J Geriatr Psychiatry; 2023 Dec; 38(12):e6042. PubMed ID: 38141048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of declined handgrip strength and HIV infection on neurocognitive impairment.
    Yuan S; Chen X; Lin H; Shi R; Li J; Xu L; Qiao S; Ding Y; He N
    J Neurovirol; 2022 Apr; 28(2):217-224. PubMed ID: 34873670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review.
    Aung HL; Aghvinian M; Gouse H; Robbins RN; Brew BJ; Mao L; Cysique LA
    AIDS Behav; 2021 Mar; 25(3):917-960. PubMed ID: 33025390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.